-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$7.00464.52% Upside
Heron Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Heron Therapeutics, Inc.?
Heron Therapeutics, Inc. has been rated by research analysts at Northland Securities, Needham in the past 90 days.